Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1β expression

Bone diseases such as osteoporosis and periodontitis are induced by excessive osteoclastic activity, which is closely associated with inflammation. Benzydamine (BA) has been used as a cytokine-suppressive or non-steroidal anti-inflammatory drug that inhibits the production of pro-inflammatory cytoki...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Han Saem Son, Jiae Lee, Hye In Lee, Narae Kim, You-Jin Jo, Gong-Rak Lee, Seong-Eun Hong, Minjeong Kwon, Nam Young Kim, Hyun Jin Kim, Jin Ha Park, Soo Young Lee, Woojin Jeong
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2020-03-01
Schriftenreihe:	Acta Pharmaceutica Sinica B
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2211383519303132
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!